Who We Are: On Therapy (with Abigail Shrier)
Why It Matters
Shrier’s analysis spotlights possible harms in current child‑focused therapy, prompting industry and policymakers to reassess treatment standards and parental rights. The conversation could influence investment and regulatory strategies in the mental‑health sector.
Key Takeaways
- •Shrier's books critique modern therapy's impact on youth
- •She argues iatrogenic harm from gender‑affirming practices
- •Highlights social media's role amplifying mental‑health anxieties
- •Calls for policy reforms to protect parental rights
- •Emphasizes need for evidence‑based treatment over ideology
Pulse Analysis
Abigail Shrier, a senior fellow at the Manhattan Institute and bestselling author, has positioned herself as a contrarian voice in American cultural journalism. Her two recent titles, "Irreversible Damage" and "Bad Therapy," examine how contemporary therapeutic practices intersect with gender politics and child welfare. The City Journal interview delves into her transition from law to journalism, revealing a data‑driven approach that challenges entrenched medical narratives. For investors and policymakers, Shrier’s work signals a growing market for alternative mental‑health frameworks.
Shrier argues that many therapeutic interventions, especially those affirming gender transition in minors, can produce iatrogenic harm—worsening mental‑health outcomes rather than alleviating them. She cites case studies and parental testimonies that suggest a rise in anxiety, depression, and regret among youth exposed to untested protocols. This critique resonates amid a broader industry shift toward evidence‑based care, prompting providers to reassess risk‑benefit calculations. Companies that supply assessment tools or counseling platforms may face heightened scrutiny as insurers and courts demand clearer efficacy data.
The interview also highlights how social media amplifies mental‑health anxieties, creating feedback loops that pressure clinicians to adopt trendy, yet unproven, treatments. Shrier calls for policy interventions that restore parental authority and prioritize longitudinal research before scaling new modalities. For stakeholders in the mental‑health ecosystem—providers, insurers, tech platforms—her perspective underscores a potential regulatory wave that could reshape service delivery and investment strategies. Monitoring legislative developments and public sentiment will be crucial for firms aiming to navigate this evolving landscape responsibly.
Comments
Want to join the conversation?
Loading comments...